Cargando…
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management
Immune checkpoint inhibitors are now approved for more than 50 indications, and increasing numbers of patients with advanced cancer are receiving immunotherapy. Immune-related adverse events that result from checkpoint inhibitors can affect any organ system. The most common kidney side effect is acu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664750/ https://www.ncbi.nlm.nih.gov/pubmed/34939017 http://dx.doi.org/10.1016/j.xkme.2021.08.008 |